Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Friday, July 3, 2026

Snapshot: Jul 3, 2026 · 6:00 PM 100 stocks analyzed

Strong Up Day

Fri, Jul 3, 2026 Complacency High

Complacency settled hard with VIX sinking 10% on a strong rally, but wild single-stock dispersion—top gainers up 23.7% average, top losers down 23.8%—revealed a market of extrem…

55% Fear evaporated as VIX plunged 10.4% despite broad strength, marking a textbook complacency regime where the S&P 500 rose 1.7%, Dow jumped 1.9%, and NASDAQ held steady at 1.9%—the market pricing in calm as July 4th approached and macro risks faded.
30% Extreme single-stock dispersion defined the day's character: 50 gainers averaging +23.7% (CLRO up 101% on merger news, CWD +90.6%, YRD +59.7%) and 50 losers averaging -23.8% (AMPGR -57.3%, TC -39%, ELTX -37.3%), a stock-picker's dream where sector and risk appetite bifurcated sharply.
15% Financial Services captured 32% of the day's top 50 gainers while Technology dominated the losers with 36% of declines; small-cap indices (Russell 2000, MidCap 400) each fell ~0.4%, indicating large-cap and special-situation plays led while traditional equity breadth lagged.

Financial Services drove 32% of gainers HLP · 3-day gainers streak SOXS · 3-day gainers streak NKTX — first appearance

Market Regime

Fri, Jul 3, 2026 Risk-On conf: low macro · prototype

+32

Tailwind −100 … +100 · + tailwind / − headwind

VIX15.8 Drawdown-1.7% Held1d · nascent SinceJul 3

Top drivers: Small-cap leadership ▲ VIX 5d momentum ▲ S&P drawdown (60d) ▲

processId: history-market-regime

Market Indexes

Fri, Jul 3, 2026 13

S&P 500

7,483.24

+125.75

+1.71%

Dow Jones

52,900.07

+979.45

+1.89%

NASDAQ Composite

25,832.67

+474.07

+1.87%

NASDAQ 100

29,329.21

−111.11

-0.38%

DJ US Total Market

74,314.56

+1,203.42

+1.65%

Russell 1000

4,084.45

+74.26

+1.85%

S&P MidCap 400

3,802.81

−19.44

-0.51%

Russell 2000

2,996.11

−11.75

-0.39%

Russell 2500

1,274.47

−5.04

-0.39%

Russell 3000

4,268.21

+73.54

+1.75%

Nasdaq Financial-100

7,406.57

+360.95

+5.12%

NIFTY 50

24,270.85

+324.60

+1.36%

VIX

15.81

−1.84

-10.42%

Biggest Gainers

Fri, Jul 3, 2026 50

CLRO

ClearOne, Inc.Technology

$6.48+$3.26

+101.2%

NASDAQ · Mkt cap $13 M

ClearOne announced a definitive merger agreement with Cortigent, Inc. (a subsidiary of Vivani Medical) on July 2, which will result in a name and ticker change, triggering a 101% stock price surge.

The merger announcement provides a clear and concrete catalyst for the massive one-day gain. ClearOne shareholders will see their company rebranded as Cortigent Holdings, Inc. under the new ticker CRGT as part of the transaction. M&A announcements of this magnitude—especially those involving ticker and name changes—typically generate significant investor interest and repricing, particularly if the deal terms are perceived as favorable or if there is pent-up value recognition. The stock's status as the 1 gainer on the day directly aligns with the timing of the dual announcements (both from Vivani and ClearOne sides) on July 2, with the price jump materializing on July 3 after market processing. Without access to deal terms, valuation multiples, or investor sentiment details, we cannot determine whether the move reflects fundamental value creation or market enthusiasm alone, but the causation between announcement and move is clear.

CWD

CaliberCos Inc.Financial Services

$1.23+$0.58

+90.6%

NASDAQ · Mkt cap $4.6 M

Caliber announced expansion of its blockchain strategy integrating Chainlink infrastructure for tokenized private real estate funds, directly triggering the 90% jump in CWD stock on July 2–3, 2026.

The headline explicitly documents a Chainlink integration announcement by Caliber that escalates its tokenization push for private real estate funds. This is a concrete strategic expansion in the blockchain and tokenization space, which typically attracts investor enthusiasm in growth-stage fintech and alternative asset platforms. The timing aligns perfectly with the stock's +90% move, and the news reflects a material business development rather than a routine update. The jump from announcement to market close suggests strong investor appetite for this blockchain-backed real estate tokenization direction. No conflicting or unrelated headlines are present in the provided feed, so the causal link appears straightforward.

YRD

Yiren Digital Ltd.Financial Services

$1.44+$0.54

+59.7%

NYSE · Mkt cap $102 M

Yiren Digital announced a $20 million share repurchase program on July 2, which likely drove the 59.68% single-day surge as investors responded positively to the capital allocation decision and potential earnings-per-share accretion.

On July 2, Yiren Digital announced a new $20 million share repurchase authorization, using its cash balance to buy back its own stock. This is a straightforward positive signal in fintech and consumer lending stocks because buybacks reduce share count, which can accrete earnings per share and signal management confidence in valuation. The timing of the surge on July 2-3 aligns directly with the announcement date. A sector tailwind in financial stocks may have provided additional momentum, but the repurchase program announcement is the specific, identifiable catalyst. The stock's low price point ($1.44) and small market capitalization typical of distressed or turnaround situations can amplify percentage moves when positive news emerges.

DSY

Big Tree Cloud Holdings LimitedConsumer Defensive

$4.47+$1.59

+55.2%

NASDAQ · Mkt cap $18 M

No news headlines were found in the last 48 hours, so the 55% jump on July 3, 2026 cannot be attributed to a specific announced event. The move likely reflects either delayed market reaction, technical trading, or unindexed corporate news.

DSY showed a dramatic 55% single-day gain without corresponding news coverage in the Yahoo Finance RSS feed over the preceding two days. This disconnect suggests either that the catalyst was released outside major news channels, occurred earlier and the market is belatedly repricing it, or that technical factors such as short-covering or options-related buying drove the move. Cloud and SaaS stocks can be volatile, particularly smaller-cap names, and a stock ranked fourth in daily gainers on this magnitude of jump typically warrants investigation into earnings releases, guidance updates, partnership announcements, or insider activity that may not yet be widely reported. Without visible headlines, the cause remains speculative.

SURG

SurgePays, Inc.Communication Services

$0.57+$0.16

+38.1%

NASDAQ

SurgePays announced on July 1st a restructured wholesale carrier agreement that lowers future subscriber costs and strengthens the balance sheet, likely driving the 38% gain on July 2nd as investors digested the positive operational development.

The company released a material announcement on July 1st detailing an amendment to its wholesale carrier agreement that modernizes commercial terms, reduces future subscriber acquisition costs, and improves the balance sheet. This is a substantive operational improvement for a micro-cap wireless services company where cost structure directly impacts profitability and cash flow. The stock's rank as the fifth biggest gainer suggests the market viewed this restructuring favorably as a step toward sustainable profitability. The broader market commentary about job data and general risk appetite on July 2nd provides context for a rally, but the company-specific news is the most direct explanation for SURG's outsized outperformance. No competing negative news or earnings misses are evident in the provided headlines.

SLBT

Horizon Space Acquisition II Corp.Healthcare

$5.99+$1.54

+34.6%

NASDAQ · Mkt cap $1.8 B

No news headlines were published in the last 48 hours, so the 34.61% jump on SLBT is not explained by reported corporate or market events. The move likely reflects technical trading, market speculation, or an unrepoted catalyst.

SLBT is a SPAC (Horizon Space Acquisition II Corp.), a blank-check acquisition vehicle. No recent headlines appear in the Yahoo Finance RSS feed, which means either no material announcement occurred or the move predates typical news coverage lag. SPACs are known to experience volatile price swings driven by merger rumors, deal timing expectations, shareholder votes, or short-covering. Given the stock trades near $6 with a large single-day gain, this could reflect renewed speculative interest around a pending business combination announcement, merger arbitrage repositioning, or technical momentum in a thinly traded security. Without news confirmation, however, any explanation remains speculative.

HLP

Hongli Group Inc.Basic Materials

$0.75+$0.19

+34.4%

NASDAQ · Mkt cap $90 M

No news headlines were found in the last 48 hours for HLP, so the 34.41% gain on July 3, 2026 cannot be attributed to a disclosed public announcement; the driver was likely technical, momentum-based, or tied to undisclosed corporate news.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it impossible to connect the sharp 34.41% gain to a specific catalyst. For a micro-cap or penny stock like HLP trading at $0.75, price movements of this magnitude can occur from several non-news sources: short covering or squeeze dynamics if the stock has significant short interest, technical chart breakouts attracting retail attention, sector rotation momentum, or delayed disclosure of material news not yet indexed by Yahoo Finance. It is also possible that a corporate announcement was made but has not yet propagated to the news feed, or that the move was driven by an undisclosed rumor or social media activity. Without either a headline or structural knowledge of HLP's float, short interest, or recent financial status, attribution remains speculative.

CMMB

Chemomab Therapeutics Ltd.Healthcare

$2.27+$0.57

+33.5%

NASDAQ · Mkt cap $15 M

No news headlines were found in the last 48 hours, so the cause of the 33.53% jump cannot be attributed to a specific announced event. The move likely reflects technical trading, market rumor, or a delayed news cycle.

Chemomab Therapeutics is a clinical-stage biotech company focused on immunotherapy, typically the type of stock that can exhibit large intraday swings on thin volume, clinical trial announcements, partnership news, or regulatory developments. With zero headlines in the provided 48-hour window, the catalyst remains opaque. The timing and magnitude of the gain suggest either a material announcement released outside the monitored news feed, short covering in a small-cap stock with limited float, sector-wide momentum in biotech, or a delayed market reaction to older news. Without corroborating headlines, we cannot confirm which of these mechanisms drove the move.

SDEV

NovaBay Pharmaceuticals, Inc.Healthcare

$1.36+$0.32

+30.8%

CCTG

CCSC Technology International Holdings Limited Ordinary SharesIndustrials

$0.91+$0.20

+28.5%

NASDAQ · Mkt cap $8.8 M

No news headlines were available in the last 48 hours, so the cause of the 28.53% gain cannot be determined from public reporting; the move likely reflects technical trading, a delayed announcement, or market sentiment shift in a low-float micro-cap.

CCSC Technology International Holdings is a small-cap NASDAQ-listed security that experienced a significant single-day jump of 28.53%, but no financial news, earnings, regulatory action, or corporate announcement appears in the available news feed for the prior 48 hours. This absence of explanation is common in micro-cap and penny-stock moves, which are often driven by factors outside traditional financial reporting: technical chart patterns, short covering, retail trading coordination, unconfirmed rumors, or delayed disclosure of company announcements made through channels not yet indexed by major news aggregators. Without access to insider trading filings, SEC Form 8-K submissions, or company press releases posted directly to investor relations pages, we cannot identify the specific catalyst. The lack of headline coverage itself is notable and suggests either a very localized event or a purely technical/speculative move.

BNRG

Brenmiller Energy LtdUtilities

$1.03+$0.22

+27.2%

LIMN

Liminatus Pharma, Inc. Class A Common StockHealthcare

$0.14+$0.03

+24.1%

NASDAQ · Mkt cap $9.4 M

No news headlines were found in the last 48 hours, so the 24% gain on LIMN stock likely stems from technical factors, retail trading interest, or untracked company developments rather than major reported events.

The absence of any Yahoo Finance headlines in the past two days makes it impossible to attribute the substantial 24% jump to a specific corporate announcement, earnings release, regulatory decision, or partnership. For a micro-cap biotech stock trading at $0.14, moves of this magnitude are not uncommon and can be driven by several untracked factors: short covering or technical rebound from oversold conditions, retail trading activity on social media or trading forums, internal company announcements not yet indexed by major news aggregators, clinical trial updates or regulatory filings posted directly to SEC databases, or shifts in sector sentiment affecting small-cap pharma broadly. Without corroborating news evidence, any explanation remains speculative.

PPCB

Propanc Biopharma, Inc.Healthcare

$1.77+$0.33

+22.9%

NASDAQ · Mkt cap $2.6 M

Propanc Biopharma announced a $5.0 million share repurchase program on July 2, which likely drove the 22.92% gain as investors typically view buybacks positively, especially for smaller-cap biotech stocks trading at low valuations.

The company initiated a $5.0 million share repurchase program with an initial $500,000 tranche planned over the next 30 days. Share buybacks are generally viewed as shareholder-friendly actions, signaling management confidence in valuation and reducing share count which can boost earnings per share. For a micro-cap biotech stock like PPCB trading at $1.77, a buyback announcement can trigger outsized percentage gains due to lower liquidity and smaller float. The timing on July 2 aligns with the stock's strong performance, though the announcement represents capital allocation rather than clinical or commercial progress. Without additional context on Propanc's cash position, burn rate, or development pipeline, we cannot assess whether this buyback is prudent capital strategy or a sign of limited near-term catalysts.

WBX

Wallbox N.V.Technology

$4.16+$0.76

+22.4%

NYSE · Mkt cap $73 M

Wallbox completed an €11.8 million equity raise and secured an additional €4 million investment on July 2, 2026, likely driving the 22.35% stock price jump as investors reacted positively to the capital raise announcement.

On July 2, 2026, Wallbox announced the completion of approximately €11.8 million in equity financing plus an additional €4 million secured investment, totaling roughly €15.8 million in new capital. For a company in the electric vehicle charging and energy management space, successful capital raises are typically viewed favorably by the market because they strengthen the balance sheet, extend runway, and reduce near-term dilution concerns. The timing of the announcement on July 2 aligns with the stock's 22.35% gain on July 3, suggesting investors responded positively to news of secured funding. The broader context of tech sector strength noted in premarket commentary on July 2 may have provided additional tailwinds, but the equity raise announcement appears to be the primary catalyst for this magnitude of move in WBX specifically.

AVXX

Defiance Daily Target 2X Long AVAV ETF

$9.04+$1.60

+21.5%

NASDAQ

No news headlines were published in the last 48 hours, but AVXX is a 2X leveraged long ETF tracking AVAV (AeroVironment), so a sharp gain in the underlying stock would be amplified roughly double in this fund, making a ~10-11% move in AVAV consistent with the observed 21.51% jump.

No recent news headlines are available to explain the move directly. However, AVXX is a daily-rebalancing leveraged ETF with 2X long exposure to AeroVironment (AVAV), a defense and aerospace technology company. The 21.51% gain in AVXX is consistent with approximately a 10-11% rally in the underlying AVAV stock, which would be amplified by the 2X leverage embedded in the fund structure. The move could reflect positive developments in AVAV itself (earnings, contract announcements, or guidance revisions) or broader sector momentum in defense and drone technology, but without access to news in the last 48 hours we cannot identify the specific catalyst. Given the lack of published headlines, the cause remains unclear.

MYPS

PLAYSTUDIOS, Inc.Communication Services

$0.63+$0.11

+20.8%

NASDAQ · Mkt cap $63 M

No headlines were available in the 48 hours prior to this 20.8% gain, so the specific catalyst is unknown. The move likely reflects technical trading, delayed news, or market sentiment unrelated to recent public announcements.

PlayStudios stock jumped over 20% on July 3, 2026, but no news headlines were captured in the Yahoo Finance RSS feed for the preceding 48 hours. This absence of identifiable catalysts makes the root cause difficult to establish with certainty. For a micro-cap or thinly traded stock like MYPS, gains of this magnitude can occur from several sources: technical trading or short covering (particularly if the stock had been under pressure), delayed dissemination of company announcements not yet indexed by major news feeds, broader market sentiment shifts, or speculative positioning. Without access to real-time trading data, volume spikes, or company filings made on or before July 3, we cannot definitively rule out legitimate fundamental news. The gap between stock action and headline coverage is a limitation of the data provided rather than evidence the move lacked substance.

MRNX

Daily Target 2X Long MRNA ETF

$55.08+$9.44

+20.7%

AMEX

No news headlines were available in the last 48 hours to explain the 20.68% gain, but MRNX is a 2X leveraged ETF tracking Moderna, so the move likely reflects a strong underlying move in MRNA stock itself rather than company-specific news.

Zero relevant news headlines appeared in the search results for the past two days, so there is no direct news catalyst to point to for this jump. However, MRNX is a daily target 2X long leveraged ETF on Moderna (MRNA), which means it amplifies daily price moves in the underlying stock by approximately two times. A 20.68% move in MRNX implies roughly a 10% move in MRNA itself. Without headline evidence, the most likely explanations are either a significant market-wide rally affecting biotech and pharma stocks, a delayed market reaction to an earlier announcement about Moderna or its pipeline, or technical factors specific to the underlying stock. Leveraged ETFs can also experience rebalancing effects or volatility-driven swings independent of fundamental news.

VACH

Voyager Acquisition Corp.Financial Services

$2.07+$0.35

+20.0%

MINE

Mayfair Gold Corp.Basic Materials

$2.57+$0.41

+19.0%

FIGG

Leverage Shares 2x Long FIG Daily ETF

$19.38+$3.04

+18.6%

NASDAQ

No headlines appeared in the past 48 hours to explain the 18.60% jump, but FIGG is a 2x leveraged long ETF on Feisty Inc (FIG), so the underlying stock likely surged roughly 9%+ on market enthusiasm or company-specific news not yet indexed by Yahoo Finance.

Yahoo Finance shows zero news headlines in the 48-hour window, so the driver cannot be identified from the provided sources. However, FIGG is a 2x daily inverse leveraged ETF tracking FIG, meaning it amplifies daily moves in the underlying stock by roughly 2x. A +18.60% move in FIGG would correspond to approximately a +9% or larger move in FIG itself. This kind of magnitude jump in a single day typically reflects either a significant positive earnings surprise, a major contract or partnership announcement, sector momentum, or a technical/short-covering event in FIG. Without access to FIG-specific news or market data from July 2-3, 2026, it is impossible to determine which catalyst drove the move. The absence of headlines suggests either a delay in news aggregation or a market-driven move based on real-time trading rather than a formal corporate disclosure.

VRXA

Veraxa Biotech Holding AGHealthcare

$2.04+$0.32

+18.3%

NASDAQ · Mkt cap $260 M

VERAXA announced initiation of cell line development for its lead BiTAC T-cell engager cancer therapy program in collaboration with ATUM, marking a key preclinical advancement toward IND-enabling activities that likely drove investor enthusiasm.

On July 2, 2026, VERAXA Biotech announced it has begun cell line development for its lead BiTAC-TCE program through a partnership with ATUM, a contract research organization specializing in cell line generation. The announcement represents tangible progress on the company's most advanced oncology asset, moving the program closer to regulatory milestones like IND or CTA filing. For early-stage biotech firms, visible progression of lead programs—especially through partnerships with established service providers—typically signals de-risking and management execution, which can trigger momentum buying. The +18.26% single-day gain ranks among the day's largest movers, consistent with a meaningful but not transformative catalyst for a small-cap biotech stock. No competing news, earnings, or regulatory decisions were reported during the window.

PLBL

Polibeli Group LtdConsumer Cyclical

$10.26+$1.58

+18.2%

NASDAQ · Mkt cap $2.2 B

Polibeli announced a non-binding MOU to evaluate a 100 MW AI computing center project in Thailand on July 2, which likely sparked the 18.2% jump as investors responded to the potential AI infrastructure opportunity.

On July 2, Polibeli disclosed entry into a non-binding Memorandum of Understanding regarding a potential 100 MW AI computing center project in Thailand. The timing of this announcement aligns precisely with the stock's 18.2% gain on July 3, suggesting direct market response. While the MOU is explicitly non-binding and the headline text is truncated, the company framed this as a potential project evaluation, which signals exposure to the high-growth AI infrastructure sector. For a digital supply chain solutions provider, diversification into AI computing infrastructure represents a material strategic pivot that could justify investor enthusiasm. However, the non-binding nature of the agreement introduces execution risk and uncertainty about financial impact, so the gain may reflect optimism tempered by deal risk rather than a certainty premium.

BMGL

Basel Medical Group Ltd Ordinary SharesHealthcare

$8.35+$1.26

+17.8%

NASDAQ · Mkt cap $8.1 M

No news headlines were found in the last 48 hours, so the 17.77% jump cannot be directly attributed to a published announcement; the move likely reflects either a delayed market reaction, technical trading, or undisclosed corporate developments.

Basel Medical Group experienced a significant single-day gain of 17.77%, ranking it 23 among daily gainers, yet no news articles appeared in the Yahoo Finance RSS feed over the past 48 hours. This disconnect suggests several possibilities. First, the catalyst may have been released outside the monitored news window or on a non-standard channel. Second, for smaller-cap medical device or biotech companies like BMGL, stock moves can be driven by technical factors such as short covering, options positioning, or algorithmic trading without fundamental catalysts. Third, the company may have issued a press release that had not yet been picked up by major news aggregators at the snapshot time. Without access to the company's investor relations page or pre-market activity, we cannot confirm whether an earnings report, clinical trial update, regulatory decision, partnership announcement, or other material event occurred on or immediately before July 3, 2026.

COSM

Cosmos Health Inc.Healthcare

$0.24+$0.04

+17.6%

NASDAQ · Mkt cap $12 M

Cosmos Health announced an expansion of its share buyback program by 770,000 additional shares on July 2, likely driving the +17.61% gain as investors interpreted the move as a positive signal of management confidence and capital allocation discipline.

The company announced on July 2 that it expanded its repurchase authorization to include an additional 770,000 shares beyond its existing 3.42 million share buyback program. Share buybacks are typically viewed as a positive signal by equity markets when executed at or near depressed valuations, as they reduce share count, support earnings per share mathematically, and signal that management believes the stock is undervalued at current prices. At $0.24 per share, Cosmos Health is trading at a penny-stock level, suggesting prior distress. The timing of this announcement just before the July 3 close, combined with the +17.61% single-day jump placing it among the top 24 gainers, suggests the market interpreted this as a credible sign of insider conviction. However, the announcement itself contains no new operational or financial data, so the gain reflects sentiment rather than fundamental improvement.

GETY

Getty Images Holdings, Inc.Communication Services

$0.90+$0.13

+17.4%

NYSE · Mkt cap $111 M

Getty Images surged 17.4% after the company rejected a CMA condition on the Shutterstock merger deal and announced it will redeem its 2030 bonds, signaling improved financial flexibility and deal certainty.

The headline directly connects Getty's stock jump to two related developments following the failed Shutterstock merger attempt. The CMA (UK Competition and Markets Authority) had imposed conditions on the proposed Shutterstock acquisition that Getty ultimately rejected, causing the deal to collapse. In response, Getty announced it will redeem merger-funded 2030 notes, which investors interpreted as a positive signal. The bond redemption suggests Getty has gained sufficient financial capacity or expects improved cash generation post-merger collapse, reducing leverage concerns. The 14-cent jump in Getty bonds and the 17% equity gain both point to relief that the company can de-risk its capital structure and move forward independently rather than being burdened by deal-related debt and regulatory uncertainty. This is a case where deal failure, combined with constructive capital management, can paradoxically drive share prices higher when the original merger looked complex or value-destructive.

BWET

Breakwave Tanker Shipping ETF

$174.29+$25.31

+17.0%

AMEX

BWET gained 17% as shipping ETFs were highlighted as a top-performing area in 1H 2026, likely boosted by geopolitical tensions and strong earnings momentum that drove the broader shipping sector rally.

The two headlines from July 1-2 identify shipping as one of the dominant ETF performance areas in the first half of 2026, with geopolitics and strong earnings cited as key tailwinds. BWET, a tanker shipping ETF, would capture exposure to this sector strength. While the headlines don't announce a specific shipping-related catalyst dated July 2-3, they confirm that shipping was already in a strong uptrend and being highlighted by financial media as a top performer. The 17% single-day jump suggests either these positive sector narratives reached broader retail/institutional audiences on July 2-3, or the stock is experiencing a delayed reaction to the positive framing. Tanker shipping is cyclical and sensitive to geopolitical disruptions (which affect shipping routes and rates), so the mention of geopolitics as a tailwind is consistent with sector strength. Without a dated announcement specific to July 2-3, we cannot pinpoint whether the move reflects new information or momentum chasing of an already-known positive narrative.

SOXS

Direxion Daily Semiconductor Bear 3X ETF

$4.51+$0.65

+16.8%

AMEX

No news headlines were found in the last 48 hours, but SOXS is a 3x inverse leveraged ETF that gains when semiconductors fall sharply, so a significant sector decline on July 2-3 likely drove the 16.84% jump.

The absence of headlines in the RSS feed does not mean no catalyst occurred; it means no Yahoo Finance headline was captured. SOXS is a leveraged bear ETF designed to move 3x inverse to the Semiconductor Select Sector Index daily. A strong selloff in semiconductor stocks on July 2 or July 3—driven by earnings misses, forward guidance cuts, rising rates, geopolitical concerns, or tech sector rotation—would mechanically produce exactly this kind of gain in SOXS. The 16.84% move is plausible for a 3x inverse product responding to a 5-6% decline in the underlying semiconductor index. Without specific headlines, the most likely category of cause is a broad semiconductor sector downturn, though ETF rebalancing or end-of-quarter positioning could also play a minor role.

CLVT

Clarivate PlcTechnology

$2.59+$0.37

+16.7%

NYSE · Mkt cap $1.3 B

No news headlines were found in the last 48 hours, so the 16.67% gain on CLVT likely reflects technical trading, delayed market reaction to prior events, or market rumors not yet captured in major news feeds.

The absence of recent news headlines makes it impossible to attribute this significant single-day gain to a specific catalyst. Clarivate is a provider of analytics and information services to the pharmaceutical, life sciences, and intellectual property sectors. A move of this magnitude in a stock with modest liquidity could reflect several scenarios: a technical rebound after oversold conditions, short covering, delayed market digestion of older announcements that haven't yet cycled through news aggregators, or unconfirmed rumors circulating among traders. Without access to intraday trading patterns, institutional flow data, or real-time social sentiment, we cannot determine which mechanism drove the move. It is also possible that relevant news was published through channels not captured by the Yahoo Finance RSS feed used here.

BIYA

Baiya International Group Inc.Technology

$0.63+$0.09

+16.6%

NASDAQ · Mkt cap $71 M

No news headlines were found in the last 48 hours, so the 16.57% gain on July 3rd cannot be directly attributed to any identifiable catalyst from public reports. The move likely stems from technical trading, a delayed announcement, or market rumor.

The absence of any Yahoo Finance headlines in the last 48 hours is notable for a stock ranking as the 29th biggest gainer of the day. This suggests the move was either driven by a catalyst that had not yet propagated to major financial news feeds by the snapshot date, or it reflects technical factors such as short covering, options expiration mechanics, or modest-volume momentum in a microcap stock. BIYA trades on NASDAQ at a very low price point ($0.63), which is typical of either distressed situations, penny stocks, or former shell companies. Such names are prone to outsized percentage moves on light news or technical rebalancing. Without corroborating headlines, we cannot rule out rumors, insider transactions, or sector-wide moves in whatever industry BIYA operates in, but none of these constitute evidence.

RVNL

GraniteShares 2x Long RIVN Daily ETF

$37.97+$5.37

+16.5%

NASDAQ

No news headlines were found in the last 48 hours, but RVNL is a 2x leveraged long ETF tracking Rivian stock, so a strong move in Rivian likely explains the amplified 16.48% gain through leverage mechanics.

The absence of news in the last 48 hours means we cannot identify a specific catalyst from headlines. However, RVNL's structure as a 2x daily leveraged long ETF on Rivian (RIVN) provides a mechanistic explanation. If Rivian stock itself moved up approximately 8% on July 2 or early July 3, the 2x leverage would produce a roughly 16% move in RVNL before fees and decay. The gain is therefore most likely attributable to an underlying move in Rivian that did not generate indexed headlines in the Yahoo Finance feed, or to normal daily volatility being amplified by the leverage mechanism. Without visibility into what drove Rivian itself, we cannot pinpoint the original catalyst.

TENX

Tenax Therapeutics, Inc.Healthcare

$15.46+$2.17

+16.3%

NASDAQ · Mkt cap $71 M

Tenax announced a late-breaking presentation of Phase 3 LEVEL trial data at ESC Congress 2026 with topline results expected in August, likely sparking optimism about a major clinical milestone in a development-stage biotech stock.

On July 2, Tenax disclosed two corporate announcements: inducement grants under Nasdaq listing rules and—more significantly—a late-breaking presentation of LEVEL clinical trial data at ESC Congress 2026, with topline results expected in August. For a Phase 3 development-stage pharmaceutical company, the announcement of imminent trial data readout is typically a high-stakes catalyst. Investors interpreting the decision to present at a major cardiology conference and the proximity of the August topline release may have viewed this as validation of trial progress and advancement toward a potential regulatory milestone. The 16.33% single-day gain ranks among the top 31 gainers on Nasdaq, consistent with the speculative nature of clinical-stage biotech where binary data events drive large swings. The general market backdrop of US equities opening higher on July 2 may have provided modest tailwind, but the company-specific news appears to be the primary driver.

MERC

Mercer International Inc.Basic Materials

$0.78+$0.11

+16.1%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 16% gain likely stems from technical factors, delayed news dissemination, or market-specific activity that was not captured by the news feeds monitored.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for MERC's 16.09% gain on July 3, 2026. Mercer International is a specialty pulp and paper company, and stocks in this sector can be sensitive to commodity price movements, currency fluctuations, and broader industrial sentiment. The move could reflect a delayed market reaction to an announcement that has not yet appeared in the monitored news feeds, a technical bounce after prior weakness, short covering, or improved sentiment in the pulp and paper sector. Without evidence of earnings, guidance changes, contract wins, or restructuring announcements, we cannot definitively attribute the move to a named catalyst. Generic possibilities include index rebalancing, positive industry data, or financial news that simply has not reached the RSS feeds yet.

TECX

Tectonic Therapeutic, Inc.Healthcare

$37.93+$5.19

+15.9%

NASDAQ · Mkt cap $585 M

No news headlines were found in the last 48 hours, so the 15.85% gain cannot be attributed to a disclosed catalyst. The move likely reflects either delayed market reaction to an earlier announcement, technical/sentiment factors, or undisclosed developments.

The absence of recent news headlines is notable given TECX's substantial single-day gain of nearly 16%, ranking it among the top 33 gainers on NASDAQ. For a biotech or therapeutic company, typical catalysts include clinical trial results, FDA decisions, partnership announcements, or earnings beats. Since none appear in the available news feed, the move could reflect several possibilities: a delayed market reaction to news released more than 48 hours ago, short-covering or technical momentum, positive sentiment in the broader biotech sector, or developments reported through non-RSS channels. Without concrete headline data linking to the move, the precise cause remains unclear, though biotech stocks are frequently subject to clinical or regulatory catalysts that may not immediately appear in mainstream feeds.

TSDD

GraniteShares 2x Short TSLA Daily ETF

$7.89+$1.05

+15.4%

MSTP

GraniteShares 2x Long MSTR Daily ETF

$14.90+$1.98

+15.3%

NASDAQ

No news headlines available in the last 48 hours, but MSTP is a 2x leveraged long ETF on Microstrategy (MSTR), so a sharp move in the underlying stock would be amplified roughly twofold in this fund.

Zero news headlines were found in the last 48 hours, so the direct cause of today's 15.32% gain cannot be identified from the provided sources. However, MSTP is a structured product designed to deliver twice the daily return of MSTR. If MSTR gained approximately 7-8% today, MSTP would naturally rise by roughly 15%, which matches the observed move. The underlying trigger for MSTR's gain remains unknown from the data provided and could stem from cryptocurrency price movements (MSTR holds significant Bitcoin), market sentiment shifts, technical trading, or any number of factors that moved the stock but did not generate captured news coverage. Without knowing MSTR's actual price action or headlines about the company, the specific catalyst cannot be determined.

MSTX

Daily Target 2X Long MSTR ETF

$9.83+$1.30

+15.2%

NASDAQ

No news headlines were published in the last 48 hours, but MSTX is a 2X leveraged ETF tracking MSTR (MicroStrategy), so the 15.24% gain likely reflects a significant move in the underlying Bitcoin proxy stock amplified by the leverage structure.

The absence of recent headlines makes direct causation impossible to establish from news flow. However, MSTX's structure provides a strong explanatory framework. As a daily target 2X long leveraged ETF on MSTR, this fund amplifies the daily moves of MicroStrategy stock, which itself is known as a Bitcoin proxy due to its substantial cryptocurrency holdings and correlation with Bitcoin price action. A roughly 7-8% move in MSTR would produce a 15% move in MSTX through the leverage multiplier. The most probable catalyst categories are therefore: (1) a significant Bitcoin price move upward in the past 24 hours, or (2) positive sentiment in tech/cryptocurrency markets broadly, or (3) company-specific positive momentum in MSTR that cascaded through the leveraged vehicle. Without headline confirmation, this remains structural inference rather than event-driven news analysis.

TSLQ

Tradr 2X Short TSLA Daily ETF

$18.68+$2.47

+15.2%

NASDAQ

No news headlines were found in the last 48 hours, but TSLQ is a 2X leveraged inverse TSLA ETF, so a 15.24% gain almost certainly reflects a sharp decline in Tesla's stock price that was amplified by the fund's inverse 2X structure.

TSLQ is designed to move opposite and at double the amplitude of Tesla's daily price action. A 15.24% gain in TSLQ would typically correspond to roughly a 7.6% decline in Tesla stock (accounting for the 2X leverage on the inverse position). No news headlines are available to confirm a specific catalyst for Tesla's decline on July 3, 2026. However, the move itself is consistent with TSLQ functioning as intended during a down day for Tesla. Possible categories of catalysts for Tesla weakness could include broad market selloff, sector rotation, earnings disappointment, regulatory news, or sentiment shifts, but without confirmed headlines or data on Tesla's actual price action that day, these remain speculative. The absence of news does not preclude a significant stock move, particularly around market-wide volatility or intraday trading dynamics.

AURA

Aura Biosciences, Inc.Healthcare

$7.74+$1.01

+15.0%

NASDAQ · Mkt cap $778 M

No news headlines were found in the last 48 hours, so the 15% gain on AURA likely reflects either a delayed market reaction to an earlier announcement, technical trading activity, or an unindexed catalyst.

The absence of recent news headlines makes attribution challenging. For a biotech stock like Aura Biosciences, typical catalysts include clinical trial readouts, regulatory decisions (FDA filings or approvals), partnership announcements, or earnings releases. The timing of a 15% single-day jump without corresponding news in the RSS feed could indicate the market is reacting to information released before the 48-hour window, or to a development that has not yet been picked up by the news aggregator. Alternatively, this could reflect short-covering, options-driven positioning ahead of a weekend, or retail interest following a previous event. Without access to intraday volume, insider activity, or the company's news release schedule, pinpointing the specific trigger is not possible.

HFFG

HF Foods Group Inc.Consumer Defensive

$1.82+$0.23

+14.5%

NASDAQ · Mkt cap $102 M

A comparison article positioning HFFG as a value option relative to KRYAY was published today, but this single piece of financial commentary alone is insufficient to explain a 14.47% intraday surge; other undisclosed catalysts likely drove the move.

The only headline provided is a valuation comparison article published at market close on 2026-07-03, which is generic financial content rather than company-specific news (earnings, guidance, contracts, or strategic announcements). While the article's positioning of HFFG as a "better value option" may have provided modest positive sentiment, a jump of 14.47% to rank 39 overall gainers suggests a weightier catalyst at play. Possibilities include an unreported insider transaction, short covering on a thinly traded microcap, technical breakout from chart support, or delayed dissemination of material company news not yet visible in the Yahoo RSS feed. HF Foods is a small-cap distributor, and stocks in this category can exhibit outsized swings on low volume or sentiment shifts.

LAFAR

LaFayette Acquisition Corp. Rights

$0.11+$0.01

+14.4%

NASDAQ

No news headlines appeared in the last 48 hours, but LAFAR is a SPAC rights offering, which can experience sharp moves on low volume, thin trading, or technical rebalancing with minimal fundamental catalyst required.

Zero news headlines were found in the last 48 hours on Yahoo Finance, so there is no documented event to point to as the cause of the 14.40% gain. LAFAR is a blank-check acquisition vehicle's rights offering, a security class characterized by minimal float, extreme sensitivity to small order flow, and frequent sharp intraday swings unmoored from company-specific news. Rights offerings in particular can gap on technical factors, options expiry, index rebalancing, or simply a handful of buy orders hitting a thin order book. Without news, the most likely explanation is a microstructure or technical event rather than fundamental information, though delayed announcements or social media chatter are possible but unconfirmed.

VRAX

Virax Biolabs Group LimitedHealthcare

$3.13+$0.39

+14.2%

NASDAQ · Mkt cap $2.5 M

No news headlines were found in the last 48 hours, so the 14.23% gain on VRAX cannot be attributed to a specific disclosed event; the move likely reflects either technical trading, delayed news pickup, or market sentiment shifts in the biotech sector.

The absence of recent headlines makes it difficult to pinpoint a concrete catalyst for VRAX's strong gain. Virax Biolabs Group is a small-cap biotech company, and such stocks are often sensitive to technical momentum, short covering, options-driven moves, or news that may not immediately appear in aggregated feeds. Possible explanations include a clinical trial update, regulatory filing, or partnership announcement that has not yet been indexed by Yahoo Finance RSS, or alternatively the move could reflect sector-wide strength in biotech equities or algorithmic buying driven by price action rather than fundamental news. Without access to company press releases, SEC filings, or other direct sources from the snapshot date, the driver remains speculative.

AIRT

Air T, Inc.Industrials

$28.87+$3.52

+13.9%

NASDAQ · Mkt cap $75 M

No news headlines were available in the last 48 hours to explain Air T's 13.89% jump on July 3, 2026, so the catalyst remains unclear from publicly reported sources.

Air T (AIRT) posted a strong single-day gain of nearly 14%, ranking it among the top 50 gainers on NASDAQ, yet no relevant news headlines appeared in the Yahoo Finance RSS feed for the preceding 48 hours. This disconnect suggests the move was driven by either a catalyst that has not yet been widely reported, or by technical factors such as short covering, options-related hedging rebalancing, or accumulation based on positive sentiment from an earlier announcement that may have been buried or delayed in indexing. Air T is a small-cap transportation and logistics services company, which can experience outsized daily swings on modest volumes or sector rotation. Without specific news, we cannot distinguish between a genuine fundamental catalyst and market technicals.

MST

Leveraged Long + Income MSTR ETF

$9.12+$1.10

+13.7%

NASDAQ

No headlines were found in the last 48 hours, so the cause of the 13.72% gain cannot be directly attributed to breaking news. The move likely reflects either broad Bitcoin strength (since MSTR is a Bitcoin proxy) or leveraged amplification of intraday momentum in the underlying.

MST is a leveraged long ETF tracking MicroStrategy, which itself is predominantly a Bitcoin proxy due to MSTR's massive balance sheet holdings of Bitcoin. Without news headlines to anchor the move, the 13.72% jump most likely stems from one of two categories. First, Bitcoin itself may have rallied substantially on July 2-3, 2026, which would automatically amplify through MSTR's leverage and then further through MST's own leverage, creating a compounded gain. Second, intraday technical momentum, short covering, or options-driven moves could drive a leveraged ETF without fundamental news, especially in a mid-cap leveraged vehicle. The absence of any news in 48 hours makes it difficult to rule out mechanical or sentiment-driven moves unrelated to company-specific catalysts.

UPC

Universe Pharmaceuticals Inc.Healthcare

$6.32+$0.76

+13.7%

NASDAQ · Mkt cap $3.5 M

No news headlines were found in the last 48 hours for UPC, so the 13.67% gain cannot be attributed to a disclosed catalyst. The move likely reflects technical trading, retail interest, or an undetected news event.

The absence of any recent headlines makes it impossible to pinpoint a specific corporate catalyst for the 13.67% jump. For a small pharmaceutical company like UPC, price movements of this magnitude without visible news typically fall into a few categories: technical bounce after oversold conditions, retail investor momentum or social media attention, short covering, sector rotation into biotech, or an announced event that has not yet propagated to Yahoo Finance's feed. Pharmaceutical stocks are sensitive to clinical trial results, FDA decisions, partnership announcements, and guidance changes, but none of those appear in the provided headlines. It is also possible that news broke after market close or through channels not captured in the 48-hour window shown here.

CVKD

Cadrenal Therapeutics, Inc. Common StockHealthcare

$3.60+$0.43

+13.6%

NASDAQ · Mkt cap $5.9 M

No news headlines were found in the last 48 hours, so the 13.56% gain cannot be attributed to a specific company announcement or market event disclosed in available sources.

Cadrenal Therapeutics is a clinical-stage biopharmaceutical company focused on cardiovascular and renal therapies, and the stock showed a notable intraday gain without any supporting news in the RSS feed during the snapshot window. For small-cap biotech stocks like CVKD, price moves of this magnitude absent headline catalysts typically stem from one of several sources: delayed dissemination of news through different channels, technical or algorithmic trading activity, short covering or momentum buying if the stock had been under pressure, rumors or social media activity not yet reflected in major news outlets, or broader market sentiment shifts in the biotech sector. Without access to the company's investor relations channels, clinical trial databases, or real-time market chat, the specific trigger remains unknown. The absence of news does not rule out a legitimate catalyst; it simply means the evidence required to identify it is not present in the provided dataset.

MOGU

MOGU Inc.Consumer Cyclical

$2.05+$0.24

+13.3%

NYSE · Mkt cap $16 M

No news headlines were found in the last 48 hours, so the 13.26% gain likely reflects a technical bounce, delayed market reaction to an earlier event, or retail interest in a low-priced stock, though the specific catalyst remains unknown.

MOGU Inc. posted a substantial single-day gain of 13.26% to reach $2.05 per share, ranking it among the top 46 gainers on July 3, 2026. However, no news headlines from Yahoo Finance appeared in the prior 48 hours to explain this move. For a small-cap Chinese e-commerce platform stock trading at such a low price point, the most common drivers of sharp daily moves absent breaking news are technical rebounds after oversold conditions, delayed reactions to earnings or company announcements released outside the 48-hour window, or increased retail trading activity and sentiment shifts. Low-priced stocks in this category can also be sensitive to sector rotation, currency movements, or broader emerging market sentiment. Without corroborating news, it is difficult to pinpoint the exact catalyst.

BRCC

BRC Inc.Consumer Defensive

$1.21+$0.14

+13.1%

NYSE · Mkt cap $203 M

No news headlines were found in the last 48 hours for BRCC, so the 13.08% gain likely stems from technical factors, delayed market reaction to an earlier announcement, or undisclosed market rumors.

The absence of any recent news headlines makes it difficult to identify a specific catalyst for the 13.08% jump in BRCC stock price on July 3, 2026. When a stock gains over 13% without corresponding news coverage, the move could reflect several possibilities. First, the stock may be responding to earnings or guidance released more than 48 hours prior that the market is still digesting. Second, a significant announcement made before the snapshot window could be driving continued momentum. Third, this could be a technical bounce from oversold levels, short-covering activity, or retail interest in a lower-priced equity. Without access to the company's current investor relations updates, financial performance, or broader market context for the beverage or consumer goods sector, we cannot determine which of these scenarios applies. BRC Inc. operates in a competitive consumer staples space where catalysts typically include earnings surprises, distribution agreements, or brand momentum shifts, but none are evident from the available headlines.

GDXU

MicroSectors Gold Miners 3X Leveraged ETNFinancial Services

$95.79+$11.04

+13.0%

AMEX

No headlines found in the last 48 hours, but GDXU's 13% gain on July 3rd likely reflects a sharp rise in gold prices or gold mining equities, since this is a 3X leveraged ETN that amplifies daily moves in the underlying gold miners index.

GDXU is a leveraged exchange-traded note that tracks gold miners with 3X daily leverage, meaning it is designed to amplify intraday or short-term moves in its underlying index by a factor of three. With no news headlines provided for the prior 48 hours, the jump cannot be tied to company-specific earnings, guidance, M&A, or regulatory events. Instead, the most probable catalyst is either a broader move in precious metals (gold price spike), a flight-to-safety rally in the gold mining sector, or technical momentum in mining equities on July 3rd. The leveraged structure means even a 4-5% move in the underlying index would translate to roughly a 13% move in this product. Without access to gold price data or mining sector ETF movements for that date, the specific trigger remains unconfirmed, but macro precious metals sentiment or risk-off positioning is the likeliest category.

IZM

ICZOOM Group Inc.Technology

$0.37+$0.04

+13.0%

NASDAQ · Mkt cap $2.8 M

No news headlines were found in the last 48 hours, so the 12.99% gain on IZM appears driven by factors other than reported company announcements, making the specific catalyst unclear.

IZM rose sharply on July 3rd without any accompanying news in the provided headlines, which limits the ability to identify a definitive cause. For a micro-cap stock trading at $0.37, catalysts could include technical rebounds from oversold conditions, short-covering activity, retail trading momentum around market holidays, or delayed disclosure of company news not yet reflected in the Yahoo Finance RSS feed. Penny stocks and very low-priced equities are particularly sensitive to sentiment shifts, algorithmic repositioning, and small-volume trading spikes. Without corroborating headlines or structural context about the company, it is impossible to determine whether this move reflects genuine business news, sentiment-driven trading, or intraday volatility.

NKTX

Nkarta, Inc.Healthcare

$3.22+$0.37

+13.0%

NASDAQ · Mkt cap $182 M

No news headlines were found in the last 48 hours, so the 12.98% gain on NKTX likely reflects either a delayed market reaction to an earlier announcement, technical trading activity, or sector momentum in biotech stocks.

The absence of any recent news headlines makes it difficult to pinpoint a specific catalyst for the 12.98% single-day gain. Nkarta is a clinical-stage cell therapy company, and stocks in this category are prone to sharp moves based on clinical trial results, regulatory interactions, financing announcements, or partnership news that may not always appear immediately in standard news feeds. The timing coinciding with a Friday before the July 4th holiday weekend could amplify lower-volume moves. Without headline evidence, the most probable explanations are a delayed market reaction to news released earlier in the week that has now propagated, short covering in a thinly traded stock, or broader sector rotation into biotech. Clinical-stage companies are particularly sensitive to sentiment shifts and technical breakouts.

Biggest Losers

Fri, Jul 3, 2026 50

AMPGR

Amplitech Group, Inc. Series A Right

$0.91−$1.22

-57.3%

NASDAQ

No news headlines are available in the last 48 hours to explain the 57% drop in AMPGR, making it impossible to identify a specific catalyst from public sources.

The absence of any news in the search results is notable for a stock experiencing the largest single-day decline on the exchange. AMPGR is a Series A Right security associated with Amplitech Group, a specialized company in the aerospace and defense sector. Rights offerings are derivative securities whose value depends heavily on the underlying common stock's performance and exercise terms. A 57% decline could reflect several categories of catalyst: a significant negative development in the parent company announced in the prior trading session that continued through today, technical factors related to the rights' exercise window or expiration date approaching, broader sector weakness in aerospace-defense, or a sharp move in the underlying common stock itself. Without current headlines, this remains speculative; the true driver could be a major corporate announcement, earnings miss, or contract loss that occurred earlier but is simply not reflected in the news feed snapshot provided.

Token Cat LimitedIndustrials

$2.93−$1.87

-39.0%

NASDAQ · Mkt cap $5.5 M

No relevant news was provided that explains the 38.96% single-day drop in TC stock. The only headline references a general Asian equities rally, which contradicts a major decline in a US-listed security.

The headline provided discusses Asian equities and American depositary receipts surging higher on Thursday morning, which is inconsistent with TC's sharp 38.96% decline on the same day. This suggests either the headline is unrelated to TC's specific move or there was a significant negative catalyst that occurred after the headline's timestamp (14:41 UTC on July 2) that was not captured in the provided news feed. For a micro-cap or lower-liquidity stock like TC trading at $2.93, common drivers of sudden large declines include missed earnings, executive departures, regulatory actions, cash flow crises, dilutive financing announcements, or loss of a major customer or partnership. Without specific news about TC itself, it is impossible to determine which category of event caused this move.

ELTX

Elicio Therapeutics, Inc.Healthcare

$3.22−$1.92

-37.4%

NASDAQ · Mkt cap $82 M

Elicio Therapeutics announced a $15 million registered direct stock offering on July 2, which likely triggered the 37% drop due to shareholder dilution concerns compounded by earlier trial disappointment referenced in the headlines.

The company announced pricing of a $15 million registered direct offering on July 2, 2026, expecting net proceeds of about $15 million. One headline explicitly frames this as "Another Blow For ELTX" following a recent "trial disappointment," suggesting investor sentiment was already negative. Direct offerings at clinical-stage biotech firms typically pressure stock prices due to immediate shareholder dilution and the signal that the company needs capital urgently. The timing of a capital raise shortly after trial setbacks amplifies negative sentiment, as it suggests the company may have fewer cash reserves than hoped and faces an uncertain pipeline. The broader market context (Wall Street opening higher, modest jobs data) appears unrelated to ELTX's specific decline, which tracks the company-specific catalysts rather than macro conditions.

LHAI

Linkhome Holdings Inc.Real Estate

$1.76−$0.98

-35.8%

NASDAQ · Mkt cap $12 M

LHAI dropped 35.77% with no company-specific news provided, suggesting the decline may be driven by technical selling, sector rotation, or undisclosed company developments rather than visible market-wide catalysts.

The only headline provided is a broad market comment about Wall Street opening higher on Thursday and weak June employment data (57,000 jobs added). This is a macro signal that typically supports equity rallies, not sharp single-stock declines. The fact that LHAI is the fourth-biggest loser despite a positive market bias suggests the move is company-specific rather than market-driven. For a micro-cap or lower-liquidity stock like LHAI, potential drivers could include undisclosed earnings disappointment, insider selling, analyst downgrades, debt covenant concerns, product delays, or competitive pressure. Without access to company news, SEC filings, or trading halts, the true catalyst remains unclear. The severity of the move (down 36% in one day) indicates either significant fundamental news, forced liquidation, or extreme loss of investor confidence.

AMPGZ

Amplitech Group, Inc. Series B Right

$1.00−$0.54

-35.1%

NASDAQ

No news headlines were found in the last 48 hours to explain the 35% drop in AMPGZ, a Series B Right offering that may be experiencing a technical or market-driven correction unrelated to company-specific events.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for this sharp 35% decline. AMPGZ is a Series B Right, a derivative security tied to Amplitech Group's equity offering structure, which makes it inherently more volatile than the underlying common stock. Rights offerings typically trade on sentiment around dilution, exercise prices, and the likelihood of shareholder participation. The move could reflect a broader market sell-off on a Friday heading into a holiday weekend, technical liquidation, or investor repositioning ahead of the rights expiration or exercise deadline. Without concrete news, the cause remains speculative, though the size of the move (ranked 5 biggest loser) suggests either a technical event or an unannounced corporate development that has not yet appeared in public headlines.

NCRA

Nocera, Inc.Consumer Defensive

$0.07−$0.03

-34.4%

NASDAQ · Mkt cap $3.2 M

Nocera announced a 1-for-30 reverse stock split effective July 7, 2026, which typically signals financial distress and triggers sell-offs as the split itself does not create value and often precedes dilution or further declines.

The headline establishes that Nocera announced a reverse stock split on July 2, effective July 7. Reverse splits are generally viewed negatively by markets because they do not change underlying enterprise value, only the number of shares outstanding. Investors often interpret reverse splits as a sign that a company's stock price has deteriorated significantly and that management is attempting to restore compliance with minimum trading price requirements or to improve optics ahead of a financing event or listing change. The 34.39% single-day decline aligns with this negative signal, as the market typically reprices downward in anticipation of the split's implementation and what it may foreshadow about the company's financial condition or near-term capital needs. The ticker remains unchanged, so this is a pure capital restructuring with no merger or fundamental business event disclosed.

PTIX

Protagenic Therapeutics, Inc.Healthcare

$0.23−$0.12

-34.3%

NASDAQ · Mkt cap $652 K

No news headlines were found in the last 48 hours to explain PTIX's 34% drop, so the cause remains unclear based on available information.

A 34% single-day decline for a stock trading at $0.23 is severe, yet no recent news headlines are available to identify a specific trigger. For a small-cap biotech company like Protagenic Therapeutics, typical catalysts driving sharp declines include adverse clinical trial results, FDA rejection or clinical hold, loss of funding or financing dilution, management changes, partnership termination, or cash runway concerns. The absence of news could mean the catalyst was released through channels not captured by Yahoo Finance RSS, emerged from regulatory filings, or reflected delayed market reaction to earlier events. Alternatively, the move could reflect technical selling in a low-liquidity micro-cap stock or resolution of a rumor, but these remain speculation without evidence.

JLHL

Julong Holding Limited Class A Ordinary SharesIndustrials

$7.33−$3.76

-33.9%

NASDAQ · Mkt cap $152 M

No news headlines were available in the last 48 hours for JLHL, making it impossible to identify a specific catalyst for the 33.90% single-day decline. The drop likely stems from a material corporate event, market rumor, or technical factor not yet captured in public headlines.

The absence of any headlines in the Yahoo Finance RSS feed for the past two days is notable given JLHL's severe 33.90% single-day loss, ranking it among the top eight biggest losers on NASDAQ for July 3, 2026. A decline of this magnitude typically requires a significant catalyst: earnings disappointment, a delisting warning or regulatory issue, sudden management change, acquisition-related dilution, or a sharp downward guidance revision. Alternatively, the move could reflect a delayed market reaction to news that has not yet been indexed by the RSS feed, or a technical event such as a forced liquidation or short squeeze reversal if the stock had been a prior momentum play. Without access to the actual news, identifying the specific cause remains speculative.

SDOT

Sadot Group Inc.Consumer Defensive

$50.55−$21.45

-29.8%

NASDAQ · Mkt cap $11 M

No news headlines were found in the last 48 hours for SDOT, so the cause of the 29.79% intraday drop cannot be confirmed from available sources. The decline likely reflects a significant negative event or announcement not yet captured by RSS feeds.

The absence of recent headlines combined with a severe single-day loss of nearly 30% suggests either a sudden market shock, a delayed reporting lag in news aggregation, or an unannounced material event. For a small-cap NASDAQ stock like SDOT, common catalysts for such sharp declines include earnings misses or warnings, insider selling, litigation announcements, regulatory setbacks, loss of a major customer or contract, financing dilution, or failed clinical/product developments if the company operates in life sciences or biotech. Without direct news confirmation, the rank as the 9th biggest loser suggests this was a broad market-moving event rather than noise, but the specific nature remains unknown from the provided evidence.

SONM

DNA X, Inc.Technology

$3.75−$1.51

-28.7%

NASDAQ · Mkt cap $3.2 M

No news headlines appeared in the last 48 hours, so the 28.71% drop cannot be directly attributed to reported company developments. The decline likely reflects sector weakness, technical selling, or undisclosed corporate events.

The absence of any Yahoo Finance headlines in the last 48 hours means we cannot point to a specific catalyst such as earnings, guidance revision, regulatory action, or M&A activity. A drop of this magnitude on a micro-cap biotech stock like DNA X, Inc. typically correlates with either broad sector rotation, accumulation of sell pressure from institutional holders, short liquidation reversals, or company-specific news that may not yet have been picked up by headline services. Without access to SEC filings, press releases, or broker alerts, the underlying driver remains obscured. The timing around the July 4th holiday weekend could also have exacerbated volume and volatility patterns.

JEM

707 Cayman Holdings Limited Ordinary SharesConsumer Cyclical

$2.30−$0.91

-28.3%

NASDAQ · Mkt cap $2.8 M

No news headlines were found in the last 48 hours for JEM, so the 28.35% single-day drop cannot be directly attributed to a specific announced event. The cause remains unclear without additional information.

JEM (707 Cayman Holdings Limited) experienced an 11th-ranked daily loss on NASDAQ with no corresponding news coverage in the Yahoo Finance RSS feed over the preceding 48 hours. This disconnect between a severe price decline and the absence of public headlines suggests several possible explanations. First, the move could be driven by technical factors such as stop-loss cascades, short covering reversals, or options-related volatility in a lower-liquidity security. Second, broad market sell-offs or sector rotation unrelated to JEM-specific news might have triggered the decline. Third, material information may have been released through channels not captured in the RSS feed (earnings announcement, SEC filing, conference call) or there may be a timing lag in news aggregation. Fourth, given the Cayman Islands domicile and the share structure, regulatory or compliance issues could have driven selling, though this would typically generate some public reporting. Without access to intraday trading data, earnings calendars, or SEC filings, the specific catalyst remains speculative.

Jianzhi Education Technology Group Company LimitedTechnology

$0.10−$0.04

-28.1%

NASDAQ · Mkt cap $4.1 M

No news headlines were available in the last 48 hours to explain JZ's 28.15% drop, so the cause remains unclear without access to market updates, regulatory filings, or company announcements on or before July 3, 2026.

The absence of any recent news headlines makes it difficult to pinpoint a specific catalyst for this sharp decline. JZ is a Chinese education technology company trading on NASDAQ at a very low price point, which suggests it may face liquidity constraints, regulatory headwinds, or structural business challenges. For micro-cap or distressed stocks trading below $1, price declines of this magnitude can be triggered by several categories: delisted or de-listing risk, unfavorable regulatory developments in China's education sector, earnings disappointments, insider selling, or technical capitulation in a stock already under pressure. Without visible news, this could also represent a delayed market reaction to an earlier announcement or a liquidity-driven move on low volume. The lack of headlines is itself noteworthy and suggests either that no material public announcement was made, or that Yahoo Finance's feed did not capture relevant sources.

PFSA

Profusa, Inc. Common StockHealthcare

$0.09−$0.04

-28.1%

NASDAQ · Mkt cap $3.4 M

Profusa announced a 1-for-25 reverse stock split effective July 7, 2026, which triggered a 28% single-day crash. Reverse splits typically signal financial distress and are viewed negatively by markets, especially when repeated within one year.

The headline explicitly states this is Profusa's second reverse share split in 2026, a major red flag for investor sentiment. Reverse splits are typically announced by companies facing delisting risk or severe capital constraints, as they mechanically reduce share count while leaving underlying economic value unchanged. Markets interpret such announcements as acknowledgment of deteriorating fundamentals. The timing—announced mid-week with implementation scheduled days later—gave shareholders immediate clarity on the catalyst. No other material news was provided that would explain the move independently, so the reverse split announcement is the direct trigger. The severity of the drop reflects both the mechanical negative signal and likely concerns about why a second split became necessary so soon.

DXF

Eason Technology LimitedFinancial Services

$0.64−$0.24

-27.6%

TERG

Leverage Shares 2X Long TER Daily ETF

$44.32−$15.88

-26.4%

NASDAQ

No news headlines are available for the last 48 hours. TERG is a 2X leveraged ETF, so a -26.38% drop most likely reflects a sharp decline in the underlying TER stock or index, amplified by the 2X leverage structure.

No relevant news headlines were found in the last 48 hours, so we cannot point to a specific corporate event, earnings release, regulatory action, or market catalyst. However, TERG is a leveraged ETF designed to deliver 2X daily returns of its underlying index or asset class. A -26.38% single-day loss is consistent with a roughly -13% move in the underlying asset, which would be amplified by the 2X leverage multiplier. The most likely causes fall into structural categories: the underlying TER-linked asset experienced a significant intraday selloff due to market turmoil, sector rotation, company-specific bad news on the underlying holdings, or broader equity market volatility. Without access to what TER tracks or why it fell, we cannot determine whether this was driven by idiosyncratic risk, sector dynamics, or systemic market stress.

GVH

Globavend Holdings LimitedIndustrials

$4.45−$1.53

-25.6%

NASDAQ · Mkt cap $2.4 M

No news headlines were available in the last 48 hours, so the cause of GVH's 25.59% drop cannot be confirmed. The decline likely stems from earnings disappointment, a guidance cut, sector weakness, or an undisclosed corporate event.

The absence of any news headlines in Yahoo Finance's last 48-hour feed makes it impossible to pinpoint a specific catalyst for GVH's steep 25.59% decline. This is a significant single-day loss for a stock trading at $4.45, yet no material announcement has been indexed. This gap could indicate several possibilities: the news may have been released outside mainstream financial media feeds, the announcement may have occurred before the 48-hour window, there may be a delayed reporting lag, or the move could be driven by technical factors, sector rotation, or market-wide volatility. Stocks in the lower-price range are sometimes subject to higher volatility and can be sensitive to volume shifts or short covering. Without access to press releases, SEC filings, or company earnings reports, attributing causation remains speculative. A researcher would need to check the company's investor relations page, recent 8-K filings, or earnings date calendar to determine what actually drove this move.

CIFG

Leverage Shares 2X Long CIFR Daily ETF

$8.94−$2.83

-24.0%

NASDAQ

No news headlines were available in the last 48 hours to explain the 24% decline, but CIFG is a 2X leveraged long ETF tracking CIFR, so its sharp drop likely reflects a significant decline in the underlying asset amplified by the leverage structure.

No recent news headlines were provided that directly caused this move. However, CIFG's structural nature as a 2X daily leveraged long ETF means it amplifies both gains and losses of its underlying index or asset CIFR by a factor of two. A 12% decline in CIFR would mechanically produce approximately a 24% decline in CIFG before accounting for any daily reset decay. The sharp loss on this date most likely stems from a substantial drop in the underlying CIFR asset itself, though without information on CIFR's price action or news, the root catalyst remains unknown. Possible categories include broad market weakness, sector-specific selling, or asset-specific negative developments in CIFR.

HKIT

Hitek Global Inc.Technology

$0.17−$0.05

-23.7%

NASDAQ · Mkt cap $27 M

HKIT fell 23.72% with no news headlines published in the last 48 hours, making the specific catalyst unknown; the drop may reflect delayed market reaction to prior events, technical selling, or undisclosed company developments.

No recent news headlines are available to explain HKIT's sharp 23.72% decline on July 3, 2026. This creates a straightforward data gap: we cannot identify a specific announced catalyst such as earnings miss, guidance cut, regulatory action, or management change from the provided sources. Penny stocks like HKIT trading at $0.17 are typically sensitive to several driver categories that may not always generate immediate headline coverage: delayed filing announcements or SEC filings (10-Q, 8-K), insider trading activity, changes in share structure or dilution events, loss of trading liquidity on certain platforms, or technical/algorithmic selling following prior resistance breaks. It is also possible the move reflects reaction to news published before the 48-hour window or information circulating in OTC markets that did not trigger major financial media coverage. Without headlines or structural context about HKIT itself, we cannot distinguish between these scenarios.

ONTX

Onconova Therapeutics, Inc.Financial Services

$22.84−$6.91

-23.2%

EDBL

Edible Garden AG IncorporatedConsumer Defensive

$0.13−$0.04

-22.5%

NASDAQ · Mkt cap $1.8 M

No news headlines were found in the last 48 hours explaining the 22.46% drop in EDBL stock, so the cause remains unclear without additional information about company announcements or market events.

The absence of any recent news headlines makes it impossible to identify a specific catalyst for the sharp 22.46% decline. EDBL is a small-cap agricultural technology company, and stocks in this category can experience significant intraday volatility from multiple sources that may not immediately appear in major news feeds. Possible categories of explanation include technical selling pressure or algorithmic rebalancing, a delayed announcement or earnings miss that hasn't yet been indexed by Yahoo Finance RSS, insider trading activity, sector-wide pressure affecting specialty agriculture stocks, or market rumors on social media or message boards that precede formal news reporting. Without access to company filings, earnings releases, or analyst notes from the past 48 hours, it is difficult to distinguish between these hypotheses. The lack of corroborating headlines suggests either that the move is driven by market microstructure rather than fundamental news, or that relevant information has not yet propagated through the news channels used for this analysis.

GLWG

Leverage Shares 2X Long GLW Daily ETF

$25.80−$7.26

-22.0%

NASDAQ

No news headlines are available for the last 48 hours, but GLWG is a 2X leveraged ETF tracking Corning Inc (GLW), so a sharp daily drop likely reflects an underlying decline in GLW stock amplified by the fund's leverage structure.

The absence of breaking news in the provided headlines makes it impossible to identify a specific catalyst for today's move. However, GLWG is a leveraged inverse or directional ETF, meaning it amplifies daily price movements of its underlying asset by 2X. A 21.96% single-day drop in a 2X levered product suggests the underlying Corning stock (GLW) fell roughly 10-11% on the day. For a major industrial materials and optical technology company like Corning to experience that magnitude of decline without news in the headlines would be unusual; the move could reflect a broad market sell-off, a delayed reaction to unannounced earnings or guidance, or a technical capitulation. Leveraged daily ETFs are also prone to decay over time if held longer than one day, though that does not explain an intraday spike.

EHGO

Eshallgo Inc. Class A Ordinary SharesIndustrials

$2.08−$0.58

-21.8%

IREG

Leverage Shares 2x Long IREN Daily ETF

$9.27−$2.49

-21.2%

NASDAQ

No news headlines were reported in the last 48 hours, but IREG is a 2x leveraged long ETF tracking IREN, so a sharp drop in the underlying stock would be amplified into a roughly 21% decline in the fund itself.

The absence of any news headlines in the provided feed makes direct attribution impossible. However, IREG's structure as a leveraged ETF offers a straightforward explanation: it holds 2x long exposure to IREN (Integrated Rail and Resources Limited), meaning it amplifies both gains and losses from its underlying. A ~10% drop in IREN would mechanically produce approximately a 20% loss in IREG before accounting for rebalancing costs and decay. The real driver is likely a significant selloff in IREN itself on July 3rd. Possible causes for IREN's decline could include broader market weakness, sector-specific headwinds in rail or resources, company-specific news not captured in the Yahoo Finance RSS feed, or technical selling. Without headlines mentioning IREN directly, we cannot pinpoint the specific catalyst, only confirm that the ETF is functioning as designed to amplify its underlying's move.

IRE

Defiance Daily Target 2X Long IREN ETF

$11.92−$3.17

-21.0%

AMEX

No news headlines were found in the last 48 hours, but IRE is a 2X leveraged long ETF tracking IREN, so a sharp decline in the underlying stock would amplify into a 21% drop.

IRE is the Defiance Daily Target 2X Long IREN ETF, a leveraged product designed to deliver twice the daily return of its underlying security. With no relevant news in the provided headlines, the 21% decline most likely reflects a substantial drop in IREN itself, which would be approximately 10-11% lower to produce a 2X amplification into this magnitude of loss. Leveraged ETFs are also sensitive to volatility decay and daily rebalancing mechanics, which can amplify losses during volatile or downward-trending periods independent of news. The absence of news does not rule out an intraday or late-afternoon selloff in IREN driven by technical factors, broad market weakness, or company-specific developments not yet reflected in the headline sources queried.

UZX

Linkage Global Inc. Class A Ordinary SharesConsumer Cyclical

$0.27−$0.07

-21.0%

NASDAQ · Mkt cap $7.8 M

No news headlines were published in the last 48 hours, so the 21% drop cannot be attributed to a disclosed event. The decline likely reflects technical selling, market sentiment shift, or undisclosed news.

The absence of recent news coverage is notable given the magnitude of the decline, ranking UZX as the 25th biggest loser on the day. For a micro-cap stock trading at $0.27, price moves of this size are not uncommon and can be driven by several mechanisms even without public headlines: technical support breaks, options expiration effects, short covering reversals, or delayed dissemination of news that has not yet reached major financial news feeds. Alternatively, the stock may have been subject to a material announcement via SEC filing or company press release that has not yet propagated to the Yahoo Finance RSS feed used here. Without access to the full information environment, specific identification of the catalyst is not possible, though micro-cap stocks in this price range are frequently volatile on modest volume.

ALAR

Alarum Technologies Ltd.Technology

$6.35−$1.67

-20.8%

NASDAQ · Mkt cap $13 M

Alarum Technologies plunged 20.82% after a law enforcement action was announced on July 2-3, 2026, likely related to the concurrent FBI-backed operation targeting malicious web traffic botnets in which the company may have been implicated or investigated.

The timing and juxtaposition of two July 3 headlines strongly suggests a causal link. Alarum issued a company update "regarding recent law enforcement action" on July 3 at 12:25 UTC, immediately following or concurrent with news of an FBI-backed crackdown on NetNut and Popa botnets announced at 13:02 UTC. The company's own press release language ("further update" referencing a July 2 announcement) indicates law enforcement involvement was already public knowledge, triggering the stock's sharp decline. Without the full text of Alarum's statement, the precise nature of the action is unclear—whether the company was a target, cooperating witness, or tangentially affected. However, any law enforcement action involving cybercrime or malicious traffic infrastructure carries severe reputational and regulatory risk for a tech company, likely explaining institutional and retail selloff. The stock's ranking as the 26th biggest loser suggests sector-wide attention to the story.

RGC

Regencell Bioscience Holdings LimitedHealthcare

$6.37−$1.66

-20.7%

NASDAQ · Mkt cap $2.9 B

RGC fell 20.67% on July 3, 2026, but no news headlines were available in the prior 48 hours to explain the move, making the specific catalyst unclear.

The absence of recent news headlines makes it impossible to identify a concrete catalyst for this sharp 20.67% decline. RGC is a small-cap biotech company, and stocks in this category are typically sensitive to clinical trial results, regulatory decisions, financing announcements, insider transactions, or shifts in investor sentiment around pipeline progress. Given the magnitude of the drop and lack of published news, potential explanations could include: an after-hours announcement or press release issued outside standard news cycles that has not yet been widely syndicated, technical selling or momentum-driven losses following an earlier negative catalyst, or a delayed market reaction to information that emerged but was not captured in the 48-hour news window. Without access to company filings, SEC notices, or direct company communications on the snapshot date, determining the true cause requires additional sources beyond the provided headlines.

MRVU

Direxion Daily MRVL Bull 2X ETF

$152.01−$38.83

-20.3%

NASDAQ

No news headlines were found in the last 48 hours, but MRVU is a 2X leveraged bull ETF on Marvell Technology, so a ~10% drop in the underlying stock would produce approximately this magnitude of loss due to the leverage multiplier.

The absence of any news in the last 48 hours makes it impossible to identify a specific catalyst from headlines. However, MRVU's structure provides a clear explanation: it is a daily-reset leveraged ETF that aims to deliver 2X the daily returns of Marvell Technology (MRVL). A 20% decline in this fund would correspond to roughly a 10% decline in MRVL itself. The underlying stock likely experienced a significant selloff on July 2 or morning of July 3, driven by factors that would need to be examined in Marvell's own news or broader semiconductor sector movements. Without access to MRVL-specific headlines or market conditions on those dates, the precise cause remains unknown, but the leverage mechanism fully accounts for why this fund moved more than the broader market.

MVLL

GraniteShares 2x Long MRVL Daily ETF

$37.93−$9.47

-20.0%

NASDAQ

No news headlines were found in the last 48 hours, but MVLL is a 2x leveraged long ETF on Marvell Technology, so a ~10% drop in the underlying stock would mechanically produce roughly this size of loss in the fund.

The absence of any headlines in the provided news feed makes it impossible to identify a specific catalyst for today's decline. However, MVLL's structure as a daily 2x leveraged long ETF on Marvell Technology (MRVL) means its performance is mechanistically tied to the underlying semiconductor stock. A 19.98% loss in a 2x leveraged product is consistent with approximately a 10% decline in MRVL itself. The most likely explanation is that Marvell Technology experienced a significant selloff today, driven by factors such as semiconductor sector weakness, a negative earnings report, analyst downgrade, broader market correction, or chip industry headwinds. Without access to MRVL's price action or semiconductor news from July 3, 2026, the specific trigger cannot be confirmed, but the leverage structure fully explains the magnitude of loss observed in MVLL.

AIP

Arteris, Inc.Technology

$35.06−$8.75

-20.0%

NASDAQ · Mkt cap $1.0 B

AIP fell 20% on July 3, but available headlines do not report any negative news; the only recent item mentions a licensing deal with SiEngine Technology from late June, which should be positive. The driver of the decline remains unclear from provided sources.

The available headlines offer no clear explanation for AIP's 20% single-day drop. The most recent substantive news, published June 24 and summarized on July 1, described a licensing agreement with Chinese automotive chipmaker SiEngine Technology—a development typically viewed as revenue-positive and growth-enabling for an IP licensing firm like Arteris. A July 3 comparison article merely notes how Cisco and AIP have performed relative to sector benchmarks, with no new operational or financial disclosure. For a semiconductor IP company, typical catalysts for sharp declines include guidance reductions, major customer loss, competitive pressure announcements, or deterioration in design-win pipelines. Without a specific negative announcement visible in the provided news feed, the 20% move may reflect broader tech sector weakness on July 3, a delayed market reaction to unmentioned news, or a technical/sentiment-driven correction after an earlier rally.

XCH

XCHG Limited American Depositary ShareIndustrials

$0.57−$0.14

-19.3%

NASDAQ · Mkt cap $21 M

No news headlines were published in the last 48 hours, so the 19.26% decline cannot be attributed to any identified corporate announcement or market event. The drop likely stems from technical selling, broader market movement, or private information flow.

The absence of any recent news headlines makes it impossible to pinpoint a specific catalyst for XCH's steep decline. For a micro-cap or thinly-traded security like an American Depositary Share trading at $0.57, price moves of this magnitude can occur from several non-news-driven sources: technical chart breaks, liquidation or redemption activity by large holders, sector-wide selloff momentum, short covering unwind, or private information circulating before public disclosure. Without headline data or visibility into order flow, volume patterns, or insider activity, attributing causation requires speculation rather than evidence. The lack of news does not rule out a material event having occurred; it may indicate the event simply has not yet appeared in the Yahoo Finance RSS feed or may be pending official disclosure.

VICR

Vicor CorporationTechnology

$282.95−$67.26

-19.2%

NASDAQ · Mkt cap $8.7 B

No news headlines were found in the last 48 hours, making it impossible to identify a specific catalyst for Vicor's 19.21% drop; the decline likely stems from earnings disappointment, guidance cut, analyst downgrade, or broad semiconductor sector weakness.

Vicor Corporation experienced a significant single-day loss of nearly 20% on July 3, 2026, yet no relevant news headlines are available from the preceding 48 hours to explain the move directly. This absence of concurrent reporting does not rule out late-afternoon announcements, after-hours developments, or pre-market guidance that may not have reached Yahoo Finance RSS feeds immediately. For a power management and semiconductor solutions company like Vicor, typical catalysts for sharp single-day declines include quarterly earnings misses, reduced forward guidance, loss of a major customer or contract, analyst rating downgrades, or broader selloffs in the semiconductor and industrial electronics sectors. The 32nd-largest losing position suggests this was a broad market day, but Vicor's proportionally steeper drop implies company-specific negative news rather than pure sector rotation. Without headline confirmation, any specific cause remains inference rather than established fact.

NBRGR

Newbridge Acquisition Limited Rights 2026-21.10.27 For Shares

$0.20−$0.05

-19.2%

NASDAQ

No news headlines were found in the last 48 hours. The 19.2% decline in this rights offering security likely reflects either broader market movements, expiration dynamics, or shifts in the underlying acquisition's perceived value, but the specific catalyst is unknown.

The absence of any news in the last 48 hours makes it impossible to identify a headline-driven catalyst for the decline. NBRGR is a rights offering tied to a 2026 share acquisition with a conversion deadline of October 27, 2027. Rights offerings of this type are sensitive to several factors: changes in the creditworthiness or deal certainty of the underlying acquisition, movements in the broader credit or equity markets that affect acquisition financing risk, technical selling ahead of expiration windows, or shifts in the implied value of the underlying shares. Without accompanying news, the most likely causes are broad market weakness in speculative credit instruments, technical rebalancing, or a negative development in the underlying acquisition that has not yet been reported by Yahoo Finance's feed.

ACLS

Axcelis Technologies, Inc.Technology

$144.50−$33.83

-19.0%

NASDAQ · Mkt cap $3.4 B

Axcelis Technologies fell 18.97% on July 3, 2026, with no news headlines in the prior 48 hours to explain the sharp decline, suggesting either delayed reporting of a material event, a broad market or sector downturn, or company-specific negative catalyst not yet reflected in financial press.

The absence of any headlines in the last 48 hours alongside an 18.97% single-day drop creates a significant gap between the magnitude of the move and available public information. Axcelis is a semiconductor equipment and ion implantation services company, sectors sensitive to capital spending cycles, competitive announcements, and customer concentration. Possible explanations include a delayed earnings release or guidance warning that has not yet appeared in RSS feeds, a customer loss or production issue disclosed after-hours or through a regulatory filing rather than a press release, broad-based semiconductor weakness on July 3 that pulled the stock down with the sector, or a technical capitulation in a previously rising stock. Without corroborating headlines or SEC filings visible in the provided data, the specific trigger remains unclear.

KUST

Kustom Entertainment, Inc.Communication Services

$1.08−$0.25

-18.8%

NASDAQ · Mkt cap $1.8 M

No news headlines were found in the last 48 hours for KUST, so the 18.8% intraday drop cannot be directly attributed to a specific public announcement or event based on available evidence.

The absence of recent news in the headline feed is notable given KUST's sharp decline to 35 worst performer today. For a micro-cap entertainment stock trading at $1.08, the causes of an 18.8% single-day drop typically fall into a few categories: delayed earnings or guidance miss, insider selling or lock-up expiration, sector rotation out of speculative entertainment holdings, liquidity-driven technical selling, or off-exchange rumors and social media activity that precedes formal news releases. Without headline confirmation, it is impossible to distinguish between these scenarios. The fact that KUST trades on NASDAQ despite the low price suggests it may have recently fallen below $1.00 or benefited from a listing event, either of which can be associated with retail interest and volatility. Intraday moves this large in low-liquidity stocks are often reversible and may reflect thin order books rather than fundamental deterioration.

ARQQ

Arqit Quantum Inc.Technology

$23.52−$5.34

-18.5%

VECO

Veeco Instruments Inc.Technology

$57.49−$13.03

-18.5%

NASDAQ · Mkt cap $2.6 B

No news headlines were available in the last 48 hours to explain VECO's 18.5% drop, so the cause remains unclear without additional reporting on earnings, guidance, contract losses, or sector headwinds.

Veeco Instruments is a semiconductor and photonics equipment manufacturer whose stock typically moves on quarterly earnings results, capital equipment orders, industry cycle conditions, and management guidance updates. An 18.5% single-day loss of this magnitude usually reflects a material negative catalyst such as a missed earnings forecast, downside revenue guidance, loss of a major customer or contract, or broader semiconductor equipment sector weakness. Without news headlines available, we cannot identify the specific trigger, but the decline is significant enough to suggest either a company-specific announcement (earnings miss, guidance reduction) or a market-wide sector rotation away from semiconductor capital equipment stocks. The absence of news coverage itself is worth noting and may indicate the announcement occurred after market open or during periods of lighter news flow.

BRLS

Borealis Foods Inc.Consumer Defensive

$1.30−$0.29

-18.2%

NASDAQ · Mkt cap $19 M

BRLS dropped 18.24% with no news reported in the last 48 hours, suggesting the move was driven by technical selling, a delayed announcement, or broader market factors rather than a company-specific catalyst.

No headlines were available in the Yahoo Finance RSS feed for the last 48 hours, so there is no concrete news-based explanation for the decline. For a stock ranked as the 38th biggest loser on a single day, the absence of reported news is notable but not uncommon in smaller-cap or micro-cap equities where coverage is sparse. The sell-off could reflect several plausible categories of cause: a technical breakdown after price resistance, short-covering reversal, delayed earnings or guidance miss that hasn't yet been picked up by news aggregators, sector rotation out of food stocks, or broader liquidity pressures. Without access to intraday volume data, company fundamentals, or insider trading activity, narrowing the cause further is not possible.

LCDL

GraniteShares 2x Long LCID Daily ETF

$0.73−$0.16

-18.1%

NASDAQ

No news headlines were reported in the last 48 hours, but the 18% drop in this 2x leveraged Lucid Motors ETF likely reflects a sharp decline in the underlying LCID stock, amplified by the fund's 2x daily leverage mechanism.

The absence of news in the provided headlines does not mean no catalyst occurred; it means the news did not appear in the Yahoo Finance RSS feed during the snapshot window. LCDL is a 2x daily leveraged long ETF tracking Lucid Motors (LCID). A leveraged ETF amplifies both gains and losses relative to its underlying asset. If LCID dropped approximately 9% on July 2 or July 3, LCDL would mechanically fall roughly 18% due to its 2x leverage multiplier. The most likely explanation is therefore a significant adverse move in Lucid Motors stock itself—potentially triggered by earnings disappointment, production delays, capital raise concerns, competitive pressure, or broad EV sector weakness. Without direct news confirmation, the cause remains inference based on the structural behavior of leveraged instruments rather than a named event.

FAMI

Farmmi, Inc.Consumer Defensive

$0.19−$0.04

-18.0%

NASDAQ · Mkt cap $3.9 M

No news headlines were available in the last 48 hours for FAMI, so the 18% decline cannot be directly attributed to a specific announced event. The drop likely reflects technical selling, market-wide pressure, or undisclosed company developments.

The absence of any Yahoo Finance headlines in the past two days makes it impossible to tie FAMI's sharp 18% decline to a concrete catalyst such as earnings, guidance revision, regulatory action, or material corporate news. For a micro-cap stock trading at $0.19, common drivers of single-day losses include technical support breaks, redemptions in small-cap index funds, shifts in retail investor sentiment, or delayed reporting of company announcements that haven't yet appeared in major news feeds. The stock's low price and position as the 40th biggest loser suggests broad market participation in the sell-off, though without news confirmation this remains inference. It is also possible that a material announcement was made but has not yet propagated through Yahoo's feed as of the snapshot date.

CRIS

Curis, Inc.Healthcare

$0.35−$0.08

-17.9%

NASDAQ · Mkt cap $4.2 M

No news headlines were found in the last 48 hours to explain CRIS's 17.89% drop, so the cause remains unclear; biotech and small-cap stocks often fall on sector weakness, clinical setbacks, or analyst downgrades that may not yet appear in public feeds.

The absence of any headlines in the Yahoo Finance RSS feed over the past 48 hours makes it impossible to pinpoint a specific catalyst for the decline. CRIS is a small-cap biotech company (Curis focuses on cancer therapeutics), and such stocks are sensitive to several invisible or delayed triggers: adverse clinical trial results or interim data that may be announced via SEC filing before media coverage; analyst downgrades or rating cuts that circulate to institutional clients before broad publication; broader sector rotation out of early-stage biotech; or technical selling in a low-liquidity name. The stock's low price of $0.35 suggests it may be under pressure from a range of operational or market forces typical of development-stage companies. Without access to SEC filings, earnings calendars, or non-headline news sources, the specific reason remains unknown.

UCTT

Ultra Clean Holdings, Inc.Technology

$106.48−$23.12

-17.8%

NASDAQ · Mkt cap $3.0 B

No negative news was disclosed in the past 48 hours; instead, Jim Cramer praised UCTT as "one of the hottest stocks" on July 3rd morning, yet the stock fell 17.84% that same day, suggesting the decline was driven by technical selling, profit-taking, or undisclosed market factors rather than compa…

The provided headline from July 3rd at 08:16:59 UTC shows Jim Cramer calling Ultra Clean Holdings a hot stock in the context of merger and acquisition opportunities, which is positive commentary. However, the stock experienced a sharp 17.84% single-day drop by market close, making this the number 42 biggest loser on the exchange. The timing is puzzling: Cramer's bullish segment aired before or during market hours on the same day as the collapse. This disconnect suggests either the market reacted negatively to something not captured in the RSS feed (perhaps specific guidance, an analyst downgrade, or disappointing earnings revision released after the Cramer segment), or the move reflects technical factors like profit-taking after a prior run-up, short covering reversal, or broader sector weakness in semiconductor or industrial equipment supply. Without additional reporting on company-specific events, the cause remains speculative.

YDES

YD Bio Limited Ordinary SharesHealthcare

$1.90−$0.41

-17.7%

NASDAQ · Mkt cap $317 M

YD Bio announced expansion of its U.S. laboratory footprint to 46 states on July 2, but the stock fell 17.75% the next day, suggesting the market either viewed the expansion as insufficient, costly, or reacted to broader biotech sector weakness unrelated to the headline.

The only news provided is a July 2 announcement that YD Bio expanded its laboratory operations to 46 states to strengthen DNA-methylation cancer detection capabilities. This is typically framed as a positive operational development, yet the stock dropped sharply the following day. The disconnect between constructive news and negative price action suggests either the market viewed the expansion as capital-intensive without corresponding revenue or near-term profit visibility, or the decline reflects sector-wide biotech volatility, profit-taking after a prior run, short-term technical weakness, or undisclosed news not captured in the RSS feed. Without earnings data, guidance changes, or negative clinical results in the headlines, the precise catalyst remains unclear.

MOVE

Corvex, Inc.Technology

$17.37−$3.69

-17.5%

VIDA

VIDA Global Inc.Technology

$2.35−$0.49

-17.3%

AMEX · Mkt cap $46 M

No news headlines were found in the last 48 hours to explain VIDA's 17.25% drop, making the cause unclear from available information.

The absence of any recent news in the Yahoo Finance RSS feed over the past 48 hours means this move cannot be attributed to a specific announced catalyst such as earnings, FDA decisions, partnerships, or guidance changes. The 17.25% decline on an otherwise quiet news day could reflect several possibilities: technical selling or profit-taking after a prior rally, a delayed market reaction to older news not captured in the 48-hour window, broad market sector weakness affecting micro-cap or biotech stocks, or unannounced insider developments not yet public. Biotech and small-cap healthcare companies like VIDA are typically sensitive to clinical trial results, regulatory action, financing events, and sector sentiment shifts, but without corroborating headlines this remains speculative.

MXL

MaxLinear, Inc.Technology

$93.12−$19.27

-17.1%

NASDAQ · Mkt cap $6.3 B

MXL dropped 17.15% on July 2–3, 2026, with no breaking news disclosed. The decline likely reflects broad market weakness, sector rotation, or pre-earnings profit-taking ahead of the July 23 earnings call.

The provided headlines do not identify any company-specific catalyst for the 17% drop. The only MXL-related news is a routine announcement of an upcoming earnings conference call on July 23, which does not by itself explain a same-day or next-day selloff. The other headline is generic market advice about following leaders. For semiconductor and analog chip companies like MaxLinear, typical catalysts include earnings surprises, guidance cuts, competitive pressure, cyclical downturn in demand, or rotation out of tech/chip stocks during broader market weakness. Without access to broader market context or intraday trading data, reasonable hypotheses center on either (1) sector-wide chip stock weakness on July 2–3, or (2) pre-earnings caution as institutional investors lock in gains before July 23 results. No specific fundamental event is evident from the headlines provided.

AEHR

Aehr Test SystemsTechnology

$69.96−$14.47

-17.1%

NASDAQ · Mkt cap $2.6 B

AEHR dropped 17.13% with no news reported in the last 48 hours, suggesting the move may be driven by technical selling, sector rotation, or an untracked catalyst such as an earnings announcement, guidance revision, or institutional rebalancing.

No headlines were provided in the Yahoo Finance RSS feed for the past 48 hours, so the cause of this steep single-day decline cannot be directly attributed to a named news event. AEHR is a semiconductor test equipment manufacturer, a sector sensitive to cyclical demand, capital spending cycles, and earnings expectations. A 17% drop of this magnitude in a stock with modest market attention typically reflects either negative earnings or guidance news that may not yet be widely indexed in financial news feeds, a technical breakdown following profit-taking or options expiration, or broader semiconductor sector weakness. Without access to real-time earnings releases, pre-market announcements, or institutional activity logs, the specific trigger remains unknown, though negative earnings or guidance revision would be the most common cause for a decline this severe in a small-cap semiconductor equity.

OUST

Ouster, Inc.Technology

$49.84−$10.18

-17.0%

NASDAQ · Mkt cap $2.6 B

Ouster announced a $200 million stock offering priced at $55.22 per share on July 2, below the previous closing price, triggering immediate selling pressure that continued through July 3 as the stock fell an additional 9.96% from the offering price to close at $49.84.

The primary catalyst is dilution from the discounted secondary offering. Ouster priced 3.62 million shares at $55.22 on July 2, which was below the prior close of $60.02, causing an immediate 7% selloff that day. The stock continued declining the next trading session, reaching $49.84 by July 3, representing a cumulative 17% drop from the pre-offering close. While the company achieved positive BABA compliance news for its Rev8 lidar sensors on July 1, which should expand access to federally funded infrastructure projects, this milestone was overshadowed by the capital raise announcement. The discount to market value, dilution of existing shareholders, and typical post-offering technical weakness combined to drive the extended decline. Retail investors characterized the move as a "healthy reset," suggesting some believe the correction has stabilized the stock near fair value after the offering.

MEI

Methode Electronics, Inc.Technology

$15.30−$3.11

-16.9%

NYSE · Mkt cap $546 M

No news headlines were found in the last 48 hours for MEI, so the 16.89% decline likely stems from an unreported development, technical selloff, sector rotation, or delayed market reaction to a previous announcement.

The absence of recent news headlines makes it impossible to identify a specific catalyst for the 16.89% drop on July 3, 2026. Methode Electronics is an automotive and industrial equipment supplier, sectors that can be sensitive to supply chain disruptions, guidance misses, production delays, or broad equity market movements. The sharp single-day decline could reflect a delayed market reaction to an earnings miss or guidance cut announced after market hours on July 2, an analyst downgrade not yet captured in the news feed, sector headwinds affecting automotive suppliers, or technical selling pressure. Without headlines or structural insight into MEI's current leverage or float conditions, the specific trigger remains unclear.

LABT

Lakewood-Amedex Biotherapeutics Inc. Common StockHealthcare

$2.75−$0.55

-16.7%

NASDAQ · Mkt cap $3.8 M

No news headlines were found in the last 48 hours, so the 16.67% drop cannot be attributed to a specific reported event. The decline is likely driven by technical selling, market conditions, or unreported developments.

The absence of any Yahoo Finance headlines in the 48-hour window preceding this move makes it impossible to link the 16.67% decline to a discrete catalyst such as earnings, regulatory action, financing announcements, or clinical setbacks. For a small-cap biotherapeutics company like LABT, typical drivers of sharp single-day moves include clinical trial results, FDA decisions, capital raises, insider trading activity, or shifts in sector sentiment. Without headline coverage, we can reasonably infer the move was either triggered by information not yet picked up by major news aggregators, a technical liquidation unrelated to fundamental news, or a market-wide repricing of biotech equities. The 50th-largest daily loser ranking suggests this was a meaningful but not extraordinary market event.